CEO Today Healthcare Awards

www.ceotodaymagazine.com CEO Today Healthcare Awards 2019 67 USA ABOUT DR. PATRICK SOON-SHIONG Dr. Patrick Soon-Shiong has served as our Chief Executive Officer and as Chairman of our Board of Directors since the formation of our company in July 2010. Dr. Soon-Shiong, a physician, surgeon and scientist, has pioneered novel therapies for both diabetes and cancer, published over 100 scientific papers, and has over 95 issued patents on groundbreaking advancements spanning myriad fields. Dr. Soon-Shiong performed the world’s first encapsulated human islet transplant, the first engineered islet cell transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA- approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer. Abraxane was approved by the FDA for metastatic breast cancer in 2005, lung cancer in 2012, and pancreatic cancer in 2013. Abraxane is now approved in many countries across the globe with sales of approximately $1.0 billion. From 1997 to 2010, Dr. Soon-Shiong served as founder, Chairman and Chief Executive Officer of two global pharmaceutical companies, American Pharmaceutical Partners (sold to Fresenius SE for aggregate consideration of up to $5.6 billion in 2008) and Abraxis BioScience (sold to Celgene Corporation for aggregate consideration of up to $3.6 billion in 2010). Dr. Soon- Shiong serves as Chairman and Chief Executive Officer of NantKwest, a publicly-traded pioneering clinical-stage immunotherapy company and an affiliate of NantHealth. Dr. Soon-Shiong also serves as Chairman of the Chan Soon-Shiong Family Foundation and Chairman and Chief Executive Officer of the Chan Soon-Shiong Institute of Molecular Medicine, a non-profit medical research organization. He currently co-chairs the CEO Council for Health and Innovation at the Bipartisan Policy Center and is a member of the Global Advisory Board of Bank of America. He is an Adjunct Professor of Surgery at the University of California, Los Angeles, or UCLA, a visiting Professor at the Imperial College of London, the Executive Director of the UCLA Wireless Health Institute, and a board member of the California Telehealth Network. The Friends of the National Library of Medicine has honored him with their Distinguished Medical Science Award. Dr. Soon-Shiong holds a degree in medicine from the University of the Witwatersrand and a M.Sc. in science from the University of British Columbia. Dr. Soon-Shiong is a board certified surgeon and a fellow of the Royal College of Physicians and Surgeons of Canada. PATRICK SOON-SHIONG Chief Executive Officer and Chairman of the Board at Nanthealth FIRM PROFILE Our Company NantHealth is a next-generation, personalized healthcare company enabling more effective treatment decisions for critical illnesses and improved patient outcomes. Our unique systems-based approach to personalized healthcare integrates novel diagnostics with large-scale biometric and phenotypic data to truly deliver precision medicine. Our Mission Optimize patient outcomes and enable value-based care through advancements in technology and precision medicine. CONTACT 1.855.WHY.NANT (1.855.949.6268) Corporate Headquarters 9920 Jefferson Boulevard Culver City, California 90232